Scorpion Therapeutics

About:

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Website: https://www.scorpiontx.com

Twitter/X: scorpiontx

Top Investors: OrbiMed, Wellington Management, Lightspeed Venture Partners, Fidelity, Invus

Description:

Scorpion Therapeutics is a clinical-stage oncology company specializing in precision medicine for cancer patients. It develops targeted small-molecule drugs to interact with validated cancer targets. It aims to leverage its platform to advance a broad pipeline of wholly-owned, optimized compounds across molecules targeting validated oncogene targets, molecules for previously undruggable targets, and molecules for novel cancer targets.

Total Funding Amount:

$420M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)scorpiontx.com

Founders:

Gaddy Getz, Gary Glick, Keith Flaherty, Liron Bar-Peled

Number of Employees:

11-50

Last Funding Date:

2024-07-16

IPO Status:

Private

© 2025 bioDAO.ai